Best CD Rates on May 24 2026 Savers Can Lock in up to 4 APY Nio Shares Surge After Launch of Chinas Largest Electric SUV Spacious Enough for NBA Star Yao Ming VietnamThailand Relations Deepen as President To Lam Visits Bangkok Trainline Upgrades FullYear Guidance for Second Time Signaling Strong Demand Premier Energies Promoters Divest Rs 2289 Crore Stake to Institutional Investors Quant Nomura Among Buyers Nvidia Earnings in Spotlight Jensen Huangs Remarks on China and Trade Policy Could Move Markets CMPS Q1 2026 Earnings Narrower Loss Drives Positive Investor Sentiment QMCO Q1 2026 Earnings EPS Beat Amidst Revenue Uncertainty as Stock Declines FRHC Q1 2026 Earnings EPS of 125 Reported Amid Mixed Market Signals IBCP Q1 2026 Earnings Earnings Beat Expectations Amid Modest Stock Decline III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure Tempus AI Inc TEM Modestly Higher as It Holds Near Key Support Micropolis AI Robotics MCRP Surges 74 as Momentum Builds Near Key Resistance Chunghwa Telecom Edges Lower as Investors Weigh Support Levels AptarGroup Holds Steady Near Support as LowVolume Drift Points to Indecision NexGel Inc NXGL Slips Slightly as Price Nears Key Support Zone Standard Chartered CEO Apologizes for LowerValue Human Capital Remark Amid AIDriven Job Cuts GRNT Q1 2026 Earnings EPS Misses Estimates by Over 80 Omeros Corporation OMER Poised Near Resistance After 2 Gain Equinox Gold EQX Q1 2026 Earnings Marginal EPS Miss Amid Gold Price Tailwinds Shares Dip 2 RDY Q1 2026 Earnings Significant EPS Miss Amplifies Investor Concerns GSBC Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline ALDX Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Progress Takes Center Stage IHS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Macro Environment ESAB Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Resilient Operations INMB Q4 2025 Earnings Narrowing Losses Amid Clinical Pipeline Progress